Similar articles

• [Clofibrate--facts and controversies].

  Sznajderman M. Sznajderman M. Pol Arch Med Wewn. 1980 Feb;63(2):101-6. Pol Arch Med Wewn. 1980. PMID: 7360682 Polish. No abstract available.
• Letter: Clofibrate in prevention of ischaemic heart-disease.

  Chakrabarti R, Meade TW. Chakrabarti R, et al. Lancet. 1975 Apr 5;1(7910):799. doi: 10.1016/s0140-6736(75)92458-7. Lancet. 1975. PMID: 48019 Clinical Trial. No abstract available.
• [Clofibrate--more harm than good?].

  Huttunen J. Huttunen J. Duodecim. 1979;95(3):97-9. Duodecim. 1979. PMID: 761565 Finnish. No abstract available.
• [Pharmacological basis for the therapeutic utilisation of hypolipedmic effects of clofibrate (author's transl)].

  Chevais M. Chevais M. Therapie. 1980 Jan-Feb;35(1):5-22. Therapie. 1980. PMID: 6998038 Review. French. No abstract available.
• Clofibrate and related compounds in hyperlipoproteinaemia. A review.

  Gustafson A. Gustafson A. Postgrad Med J. 1975;51(8):66-71. Postgrad Med J. 1975. PMID: 768950 Review. No abstract available.